Available to sourceHuman Prescription DrugGastrointestinal

POKONZA (potassium chloride)

1.125 g/1.185g · Powder for Solution

By Carwin Pharmaceutical Associates, LLC

NDC: 15370-306
Route: Oral
Therapeutic class: Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative , Potassium Compounds [CS], Potassium Salt
Marketing category: NDA

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.